ERS International Congress 2021: highlights from the Respiratory Clinical Care and Physiology Assembly
- PMID: 35615417
- PMCID: PMC9125042
- DOI: 10.1183/23120541.00710-2021
ERS International Congress 2021: highlights from the Respiratory Clinical Care and Physiology Assembly
Abstract
It is a challenge to keep abreast of all the clinical and scientific advances in the field of respiratory medicine. This article contains an overview of laboratory-based science, randomised controlled trials and qualitative research that were presented during the 2021 European Respiratory Society International Congress within the sessions from the five groups of the Assembly 1 - Respiratory clinical care and physiology. Selected presentations are summarised from a wide range of topics: clinical problems, rehabilitation and chronic care, general practice and primary care, electronic/mobile health (e-health/m-health), clinical respiratory physiology, exercise and functional imaging.
Copyright ©The authors 2022.
Conflict of interest statement
Conflict of interest: T. Gille reports personal fees from Boehringer Ingelheim and Roche, and nonfinancial support from Oyxvie, LVL Medical and Vitalaire (oxygen providers), outside the submitted work. P. Sivapalan reports personal fees from AstraZeneca, GSK, Boehringer Ingelheim and Chiesi Farmaceutici, outside the submitted work. C. Vicente reports personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Mylan, outside the submitted work. N. Das owns stock options in ArtiQ, which develops commercial AI software for lung function diagnostics, outside the submitted work. C. Rolland-Debord reports personal fees from Sanofi, Novartis and AstraZeneca, outside the submitted work. I. Vogiatzis is an associate editor of this journal. F.M.E. Franssen reports grants and personal fees from AstraZeneca, and personal fees from Boehringer Ingelheim, Chiesi, GlaxoSmithKline, MSD and Novartis, outside the submitted work. L.E.G.W. Vanfleteren reports personal fees from AstraZeneca, Novartis, GlaxoSmithKline, Resmed, Boehringer Ingelheim, Verona Pharma and AGA, outside the submitted work; and is an associate editor of this journal. G. Kaltsakas, S.B. Kolekar, M. Armstrong, R. Tuffnell, R.A. Evans, G. Vagheggini, L.H. Degani-Costa, V. Poberezhets, S. Bayat and H. Pinnock have nothing to disclose.
References
-
- Ali Z, Ahmed S, Makan A, et al. . Hospital re-admissions and deaths associated with COVID-19 illness: survival analysis. Eur Respir J 2021; 58: Suppl. 65, OA4194.
Publication types
LinkOut - more resources
Full Text Sources